2-(Cyclopropanesulfonamido)-N-(2-ethoxy-5-fluorophenyl)benzamide

ID: ALA5172913

Chembl Id: CHEMBL5172913

PubChem CID: 168273467

Max Phase: Preclinical

Molecular Formula: C18H19FN2O4S

Molecular Weight: 378.43

Names and Identifiers

Canonical SMILES:  CCOc1ccc(F)cc1NC(=O)c1ccccc1NS(=O)(=O)C1CC1

Standard InChI:  InChI=1S/C18H19FN2O4S/c1-2-25-17-10-7-12(19)11-16(17)20-18(22)14-5-3-4-6-15(14)21-26(23,24)13-8-9-13/h3-7,10-11,13,21H,2,8-9H2,1H3,(H,20,22)

Standard InChI Key:  TXZPRVKJSAUJSV-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA5172913

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 378.43

Molecular Weight (Monoisotopic): 378.1050

AlogP: 3.38

#Rotatable Bonds: 7

Polar Surface Area: 84.50

Molecular Species: NEUTRAL

HBA: 4

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 6

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 7.60

CX Basic pKa: ┄

CX LogP: 2.55

CX LogD: 2.37

Aromatic Rings: 2

Heavy Atoms: 26

QED Weighted: 0.77

Np Likeness Score: -2.01

References

1. Sharma S, Peng Q, Vadukoot AK, Aretz CD, Jensen AA, Wallick AI, Dong X, Hopkins CR..  (2022)  Synthesis and Biological Characterization of a Series of 2-Sulfonamidebenzamides as Allosteric Modulators of MrgX1.,  13  (5.0): [PMID:35586421] [10.1021/acsmedchemlett.2c00100]

Source

Source(1):

• Scientific Literature